Search Results - "Martin Tolstrup"
-
1
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
Published in The lancet HIV (01-10-2014)“…Summary Background Activating the expression of latent virus is an approach that might form part of an HIV cure. We assessed the ability of the histone…”
Get full text
Journal Article -
2
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
Published in PLoS pathogens (01-09-2015)“…Pharmacologically-induced activation of replication competent proviruses from latency in the presence of antiretroviral treatment (ART) has been proposed as a…”
Get full text
Journal Article -
3
Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis
Published in Frontiers in immunology (23-11-2021)“…Introduction of vaccines against COVID-19 has provided the most promising chance to control the world-wide COVID-19 pandemic. However, the adenovirus-vector…”
Get full text
Journal Article -
4
The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies
Published in Frontiers in immunology (11-06-2020)“…Toll-like receptors (TLRs) are a family of pattern recognition receptors and part of the first line of defense against invading microbes. In humans, we know of…”
Get full text
Journal Article -
5
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Survey Among 17 971 Healthcare and Administrative Personnel at Hospitals, Prehospital Services, and Specialist Practitioners in the Central Denmark Region
Published in Clinical infectious diseases (02-11-2021)“…Abstract Background The objective of this study was to perform a seroprevalence survey on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among…”
Get full text
Journal Article -
6
Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections
Published in Nature communications (01-08-2022)“…SARS-CoV-2 variants of concern have continuously evolved and may erode vaccine induced immunity. In this observational cohort study, we determine the risk of…”
Get full text
Journal Article -
7
Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individuals
Published in AIDS (London) (01-07-2019)“…DESIGN:This was an exploratory, single-arm clinical trial that tested the immune enhancement effects of 24-weeks of Toll-like receptor 9 (TLR9) agonist…”
Get full text
Journal Article -
8
Strategies for enhancing CAR T cell expansion and persistence in HIV infection
Published in Frontiers in immunology (21-08-2023)“…Chimeric Antigen Receptor (CAR) T cell therapies are tremendously successful in hematological malignancies and show great promise as treatment and curative…”
Get full text
Journal Article -
9
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
Published in Nature communications (29-10-2022)“…In simian-human immunodeficiency virus (SHIV)-infected non-human primates, broadly neutralizing antibodies (bNAbs) against the virus appear to stimulate T cell…”
Get full text
Journal Article -
10
The Potential of Long-Acting, Tissue-Targeted Synthetic Nanotherapy for Delivery of Antiviral Therapy Against HIV Infection
Published in Viruses (07-04-2020)“…Oral administration of a combination of two or three antiretroviral drugs (cART) has transformed HIV from a life-threatening disease to a manageable infection…”
Get full text
Journal Article -
11
SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses
Published in EBioMedicine (01-02-2021)“…Upon SARS-CoV-2 infection, most individuals develop neutralizing antibodies and T-cell immunity. However, some individuals reportedly remain SARS-CoV-2 PCR…”
Get full text
Journal Article -
12
Broad activation of latent HIV-1 in vivo
Published in Nature communications (08-09-2016)“…The ‘shock and kill’ approach to cure human immunodeficiency virus (HIV) includes transcriptional induction of latent HIV-1 proviruses using latency-reversing…”
Get full text
Journal Article -
13
HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days--Implications for HIV Remission
Published in PLoS pathogens (01-07-2015)“…HIV infection can be effectively controlled by anti-retroviral therapy (ART) in most patients. However therapy must be continued for life, because interruption…”
Get full text
Journal Article -
14
Discovery of neutralizing SARS-CoV-2 antibodies enriched in a unique antigen specific B cell cluster
Published in PloS one (20-09-2023)“…Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends on therapeutic antibodies or small-molecule drugs in cases…”
Get full text
Journal Article -
15
Nanobody‐mediated complement activation to kill HIV‐infected cells
Published in EMBO molecular medicine (11-04-2023)“…The complement system which is part of the innate immune response against invading pathogens represents a powerful mechanism for killing of infected cells…”
Get full text
Journal Article -
16
Comparable human reconstitution following Cesium-137 versus X-ray irradiation preconditioning in immunodeficient NOG mice
Published in PloS one (29-10-2020)“…Humanized mouse models are used extensively in research involving human pathogens and diseases. However, most of these models require preconditioning…”
Get full text
Journal Article -
17
Impacts of HIV Cure Interventions on Viral Reservoirs in Tissues
Published in Frontiers in microbiology (21-08-2019)“…HIV reservoirs persist in infected individuals despite combination antiretroviral therapy and can be identified in secondary lymphoid tissues, in intestinal…”
Get full text
Journal Article -
18
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity
Published in EBioMedicine (01-06-2021)“…The SARS-CoV-2 pandemic currently prevails worldwide. To understand the immunological signature of SARS-CoV-2 infections and aid the search and evaluation of…”
Get full text
Journal Article -
19
A novel SARS-CoV-2 Beta RBD DNA vaccine directly targeted to antigen-presenting cells induces strong humoral and T cell responses
Published in Scientific reports (02-11-2023)“…Throughout the COVID-19 pandemic, several variants of concern (VoC) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have evolved, affecting…”
Get full text
Journal Article -
20
Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial
Published in The lancet HIV (01-10-2016)“…Summary Background Immune priming before reversal of latency might be a component of a functional HIV cure. To assess this concept, we assessed if therapeutic…”
Get full text
Journal Article